8:00 am Check In & Morning Refreshments
8:25 am Chair’s Opening Remarks
8:30 am Exploring the State of Play for Ophthalmic Drug Delivery to the Retina
Synopsis
- Examining recent developments in retinal drug delivery devices
- Uncovering innovation in suprachoroidal injection and subretinal delivery devices
- Exploring multiple routes of subretinal administration
Advancing Retinal Therapy With Sustained Release Implants to Reduce Treatment Frequency
9:00 am Uncovering the Journey of Genentech’s Susvimo Port Delivery System’s from Challenges to FDA Reapproval
Synopsis
- Delving into the process of the reapproval journal
- Uncovering the required modifications to ensure safety
- Exploring clinical data on the efficacy of Susvimo
9:30 am Speed Networking Break
Synopsis
A prime chance to make the most of the in-person networking with a niche community of ophthalmic delivery
professionals working in the space. This session is designed to maximize your introduction to numerous new individuals and serve as a catalyst for ongoing discussions during the summit
10:00 am Morning Break
Advancements in Large Volume Formulations & High Viscosity Injectable Drug Delivery
11:00 am Unlocking Drug Delivery Mechanics for Extended Release Implants
Synopsis
- Assessing the impact of formulation composition on drug release profiles
- Relating matrix biodegradation and drug release
- Developing into in vitro and in vivo performance correlation
11:30 am Focused Panel: Establishing Robust Clinical Trial Design to Overcome Past Failings
Synopsis
- Patient-Centric Approaches: How can clinical trial design be optimized to minimize patient burden and improve adherence
- Site-Specific Considerations: How can sites be better supported to ensure successful study execution?
- Innovative Trial Design: Explore the latest advancements in clinical trial design, such as decentralized trials, virtual visits, and innovative data collection methods
12:00 pm Networking Lunch
Overcoming Inflammatory Responses to Maximize Therapeutic Effect
1:00 pm Exploring the Evolving Landscape of Regulatory Approvals for Combination Products
Synopsis
- Landscape overview of current regulatory requirements
- Device design solutions to address regulatory challenges
- Future of ophthalmic drug delivery in clinical trials
1:30 pm Navigating the Safety Landscape of Novel Drug Delivery
Synopsis
- Evaluating acceptable safety goals for novel therapeutic deliveries
- Addressing safety challenges associated with novel delivery technologies
- Managing adverse events related to delivery technologies
2:00 pm Afternoon Break & Poster Session
Synopsis
Immerse yourself in an engaging and relaxed atmosphere that encourages meaningful conversations and relationship
building. You’ll also have the chance to explore a range of exciting poster presentations of the latest ophthalmic delivery strategies and showcase your own innovations.
Advancing Drug Formulations & Combinations to Achieve Sustained Release
3:00 pm Advancing Targeted, Compartmentalized & Long-Acting Depot Delivery: Synergistic Combination of Particulate Formulation & Suprachoroidal Route of Administration
Synopsis
- Outlining the aqueous suspension depot formation of small molecule therapeutics capabilities
- Exploring the potential of suprachoroidal delivery as targeted and compartmentalized delivery platform
- Delving into preclinical and clinical assessment of suprachoroidal axitinib and triamcinolone acetonide
3:30 pm Enhancing Ocular Drug Delivery Through Combined Microparticles, Nanoparticles & Hydrogels
Synopsis
- Extending drug release and improving localization in the intraocular space
- Reducing burden and frequency of treatment